{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:29:19Z","timestamp":1790494159772,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.vaccine.2022.03.041","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:05:20Z","timestamp":1648746320000},"page":"2679-2695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Efficacy, immunogenicity, and safety of available vaccines in children on biologics: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"40","author":[{"given":"Chiara","family":"Gertosio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Licari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"De Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Rebuffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1476-4752","authenticated-orcid":false,"given":"Elena","family":"Chiappini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luigi","family":"Marseglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2022.03.041_b0005","doi-asserted-by":"crossref","first-page":"357","DOI":"10.24953\/turkjped.2017.04.001","article-title":"Current information about vaccination practice in pediatric rheumatic diseases and recommendations for future applications","volume":"59","author":"Acari","year":"2017","journal-title":"Turk J Pediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2022.03.041_b0010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/1203475418811335","article-title":"Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies","volume":"23","author":"Papp","year":"2019","journal-title":"J Cutan Med Surg"},{"issue":"22","key":"10.1016\/j.vaccine.2022.03.041_b0015","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.3748\/wjg.v17.i22.2708","article-title":"Inflammatory bowel disease in travelers: Choosing the right vaccines and check-ups","volume":"17","author":"Esteve","year":"2011","journal-title":"WJG"},{"issue":"10","key":"10.1016\/j.vaccine.2022.03.041_b0020","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/ard.2011.150193","article-title":"EULAR: EULAR recommendations for vaccination in paediatric patients with rheumatic diseases","volume":"70","author":"Heijstek","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2022.03.041_b0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.crohns.2009.02.010","article-title":"European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"3","author":"Rahier","year":"2009","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.vaccine.2022.03.041_b0030","unstructured":"Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence. MMWR Recomm Rep 1993;42:1\u201318 [PMID: 8474421]."},{"key":"10.1016\/j.vaccine.2022.03.041_b0035","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00054725-200409000-00028","article-title":"Guidelines for immunizations in patients with inflammatory bowel disease","volume":"10","author":"Sands","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.vaccine.2022.03.041_b0040","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6(7):e1000097. doi: 10.1371\/journal.pmed.1000097PubMedGoogle Scholar.","DOI":"10.1371\/journal.pmed.1000097"},{"issue":"15","key":"10.1016\/j.vaccine.2022.03.041_b0045","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting: Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.vaccine.2022.03.041_b0050","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"key":"10.1016\/j.vaccine.2022.03.041_b0055","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"14","key":"10.1016\/j.vaccine.2022.03.041_b0060","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1177\/0961203318808589","article-title":"Immunogenicity of sequential 13-valent conjugated and 23-valent unconjugated pneumococcal vaccines in a population of children with lupus","volume":"27","author":"Gorelik","year":"2018","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.vaccine.2022.03.041_b0065","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2008.120","article-title":"Immune response to influenza vaccine in children with inflammatory bowel disease","volume":"104","author":"Lu","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.vaccine.2022.03.041_b0070","doi-asserted-by":"crossref","first-page":"E160","DOI":"10.1002\/ibd.21892","article-title":"Response to hepatitis A vaccine in children with inflammatory bowel disease receiving infliximab","volume":"17","author":"Moses","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.03.041_b0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ajg.2011.295","article-title":"Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab","volume":"107","author":"Moses","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.vaccine.2022.03.041_b0080","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.cgh.2007.02.035","article-title":"Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease","volume":"5","author":"Mamula","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.03.041_b0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/03009742.2012.709272","article-title":"Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis","volume":"42","author":"Aikawa","year":"2013","journal-title":"Scand J Rheumatol"},{"issue":"13","key":"10.1016\/j.vaccine.2022.03.041_b0090","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1177\/0961203313505926","article-title":"Immunogenicity and safety of two doses of a non-adjuvanted influenza A H1N1\/2009 vaccine in young autoimmune rheumatic diseases patients","volume":"22","author":"Aikawa","year":"2013","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.vaccine.2022.03.041_b0095","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.vaccine.2014.12.030","article-title":"Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy","volume":"33","author":"Aikawa","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2022.03.041_b0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ibd.21706","article-title":"Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease","volume":"18","author":"deBruyn","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2022.03.041_b0105","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/MIB.0000000000000615","article-title":"Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy: A Randomized Trial","volume":"22","author":"deBruyn","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2022.03.041_b0110","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/ibd\/izy366","article-title":"Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease","volume":"25","author":"deBruyn Jennifer","year":"2019","journal-title":"Inflamm Bowel Dis"},{"issue":"38","key":"10.1016\/j.vaccine.2022.03.041_b0115","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1016\/j.vaccine.2013.06.086","article-title":"Evaluation of immune responses to combined hepatitis A and B vaccine in HIV-infected children and children on immunosuppressive medication","volume":"31","author":"Belderok","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2022.03.041_b0120","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/ken436","article-title":"Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept","volume":"48","author":"Borte","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.vaccine.2022.03.041_b0125","doi-asserted-by":"crossref","unstructured":"Camacho-Lovillo MS, Bulnes-Ramos A, Goycochea-Valdivia W, Fernandez-Silveira L, Nunez-Cuadros E, Neth O. Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay. Pediatr Rheumatol Online J 2017;15(1): 62-017-0190-0.","DOI":"10.1186\/s12969-017-0190-0"},{"issue":"5","key":"10.1016\/j.vaccine.2022.03.041_b0130","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.vaccine.2011.11.083","article-title":"Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis","volume":"30","author":"Dell\u2019Era","year":"2012","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2022.03.041_b0135","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1016\/j.vaccine.2017.04.015","article-title":"Varicella vaccination elicits a humoral and cellular response in children with rheumatic diseases using immune suppressive treatment","volume":"35","author":"Groot","year":"2017","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2022.03.041_b0140","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/annrheumdis-2011-200637","article-title":"Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study","volume":"71","author":"Heijstek","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.03.041_b0145","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-018-0235-z","article-title":"The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey","volume":"16","author":"Jeyaratnam","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.vaccine.2022.03.041_b0150","doi-asserted-by":"crossref","unstructured":"Loras C, Gisbert JP, Saro MC, Piqueras M, Sanchez-Montes C, Barrio J, et al. mpact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3). J Crohns Colitis 2014;8(11):1529\u201338, European Crohn's and Colitis Organisation. Published by Elsevier B.V, England.","DOI":"10.1016\/j.crohns.2014.06.009"},{"issue":"3","key":"10.1016\/j.vaccine.2022.03.041_b0155","first-page":"436","article-title":"Safety and efficacy of influenza vaccination in a prospective longitudinal study of 31 children with juvenile idiopathic arthritis","volume":"30","author":"Toplak","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.03.041_b0160","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s00467-013-2538-0","article-title":"Seroprotection for hepatitis B in children with nephrotic syndrome","volume":"28","author":"Mantan","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1016\/j.vaccine.2022.03.041_b0165","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/MPG.0000000000001580","article-title":"Incidence of Low Seroimmunity to Hepatitis B Virus in Children With Inflammatory Bowel Disease","volume":"65","author":"Watts","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.vaccine.2022.03.041_b0170","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/INF.0b013e3181f7ce44","article-title":"Immunogenicity of influenza vaccine in children with pediatric rheumatic diseases receiving immunosuppressive agents","volume":"30","author":"Ogimi","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2022.03.041_b0175","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3109\/s10165-012-0595-z","article-title":"Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab","volume":"22","author":"Shinoki","year":"2012","journal-title":"Mod Rheumatol"},{"issue":"11","key":"10.1016\/j.vaccine.2022.03.041_b0180","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/art.41004","article-title":"Rapid and Sustained Long-Term Efficacy and Safety of Canakinumab in Patients With Cryopyrin-Associated Periodic Syndrome Ages Five Years and Younger","volume":"71","author":"Brogan","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.vaccine.2022.03.041_b0185","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/rheumatology\/kex185","article-title":"Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study","volume":"56","author":"Jaeger","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.vaccine.2022.03.041_b0190","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1136\/ard.2011.152728","article-title":"Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes","volume":"70","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2022.03.041_b0195","doi-asserted-by":"crossref","unstructured":"Zeitlin PL, Leong M, Cole J, Mallory RM, Shih VH, Olsson RF, et al. ALIZE study investigators. Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial. J Asthma Allergy 2018;11:181\u201392.","DOI":"10.2147\/JAA.S172338"},{"issue":"5","key":"10.1016\/j.vaccine.2022.03.041_b0200","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/MPG.0b013e3181bab351","article-title":"Varicella vaccination in children with inflammatory bowel disease receiving immunosuppressive therapy","volume":"50","author":"Lu","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"10.1016\/j.vaccine.2022.03.041_b0205","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1128\/CVI.00309-12","article-title":"Relapse of systemic juvenile idiopathic arthritis after influenza vaccination in a patient receiving tocilizumab","volume":"19","author":"Shimizu","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2022.03.041_b0210","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/ccr3.1149","article-title":"Live-attenuated vaccines in a cryopyrin-associated periodic syndrome patient receiving canakinumab treatment during infancy","volume":"5","author":"Watanabe","year":"2017","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.vaccine.2022.03.041_b0215","unstructured":"Lu Y1, Bousvaros A. Immunizations in children with inflammatory bowel disease treated with immunosuppressive therapy. Gastroenterol Hepatol (NY) 2014 Jun;10(6):355\u201363."},{"issue":"2","key":"10.1016\/j.vaccine.2022.03.041_b0220","article-title":"Infectious Complications With the Use of Biologic Response Modifiers in Infants and Children","volume":"138","author":"Dele","year":"2016","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.vaccine.2022.03.041_b0225","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/rheumatology\/ker102","article-title":"Vaccination of children and adolescents with rheumatic diseases","volume":"50","author":"Dell'Era","year":"2011","journal-title":"Rheumatology (Oxford)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22003413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22003413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:11:00Z","timestamp":1759403460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22003413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":45,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0264410X22003413"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.03.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, immunogenicity, and safety of available vaccines in children on biologics: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.03.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}